Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Biosplice Therapeutics
AddedFeb 13, 2024
UpdatedJun 18, 2026
Biosplice Therapeutics

Biosplice Therapeutics

Late Stage Private

Biosplice Therapeutics: Pioneering tissue regeneration and degenerative disease solutions via Wnt pathway modulation.

HQ
San Diego, CA, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

Founded in San Diego, Biosplice Therapeutics focuses on pioneering tissue regeneration and solutions for degenerative diseases through Wnt pathway modulation. Their core mission is to restore health by delivering first-in-class therapies that harness alternative splicing, addressing unmet medical needs in regenerative medicine and oncology. The company develops therapeutics aimed at conditions like osteoarthritis, where no drugs currently arrest disease progression, and seeks to overcome the diversity and adaptability of lethal cancers.

Biosplice Therapeutics has garnered attention for its innovative approach and significant potential impact on medical treatments. Notable affiliated individuals include key researchers and scientists specializing in molecular biology and regenerative medicine. The company has achieved milestones in preclinical and clinical trials, demonstrating promising results in tissue regeneration and cancer therapy. Their work has the potential to revolutionize treatment paradigms, offering hope to millions of patients suffering from currently untreatable conditions.

Biosplice Therapeutics - Similar Companies

Blade Therapeutics logo

Blade Therapeutics

Spinogenix logo

Spinogenix

spinogenix.com

Amplicore logo

Amplicore

Angiocrine Bioscience logo

Angiocrine Bioscience

Spine BioPharma logo

Spine BioPharma

spinebiopharma.com

DiscGenics logo

DiscGenics

discgenics.com

Surrozen logo

Surrozen

surrozen.com

Retro Biosciences logo

Retro Biosciences

retro.bio

SphynKx Therapeutics logo

SphynKx Therapeutics

Pliant Therapeutics logo

Pliant Therapeutics

pliantrx.com

Endogena Therapeutics logo

Endogena Therapeutics

Spyryx Biosciences logo

Spyryx Biosciences

Biotheryx logo

Biotheryx

biotheryx.com

Marlinspike Therapeutics logo

Marlinspike Therapeutics

Regenemed logo

Regenemed

regenemed.com

Biosplice Therapeutics - Quick Facts

Who are Biosplice Therapeutics' competitors?

Companies similar to Biosplice Therapeutics include Blade Therapeutics, Spinogenix, Amplicore and Angiocrine Bioscience.

When was Biosplice Therapeutics founded?

Biosplice Therapeutics was founded in 2008.

Where is Biosplice Therapeutics' headquarters located?

Biosplice Therapeutics' headquarters is located in San Diego, CA, US.

When was Biosplice Therapeutics' last funding round?

Biosplice Therapeutics' most recent funding round was for $120M (USD) in April 2021.

How much has Biosplice Therapeutics raised to-date?

As of Apr 15, 2021, Biosplice Therapeutics has raised a total of $778M (USD).

How many employees does Biosplice Therapeutics have?

Biosplice Therapeutics has 63 employees as of Feb 5, 2024.

Biosplice Therapeutics - Classification

Industry
  • Therapeutics
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Development
  • Therapeutics
Tags
  • Biotech
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 13 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research